Related references
Note: Only part of the references are listed.Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Inborn errors of apolipoprotein A-I metabolism: implications for disease, research and development
Paolo Zanoni et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Is it time to reconcile HDL with cardiovascular diseases and beyond? An update on a paradigm shift
Laurent O. Martinez et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Lipid-Lowering Agents Targets Beyond PCSK9
Robert A. Hegele et al.
CIRCULATION RESEARCH (2019)
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki et al.
NATURE REVIEWS NEUROLOGY (2019)
A novel APOA1 mutation in a patient with renal amyloidosis: unveiling amyloid by next-generation sequencing
Francesca Cottini et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options
Myrto Moutafi et al.
BMC MEDICAL GENETICS (2019)
Novel apolipoprotein AII mutation associated renal amyloidosis and fibrillary/immunotactoid cardiomyopathy
Joanne Brown et al.
PATHOLOGY (2019)
Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition
Danyang Li et al.
BMC NEPHROLOGY (2019)
Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant
Konstantinos Liapis et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)
A case of apolipoprotein A-I deficiency due to carboxyl-terminal truncation
Sho Tanaka et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis
Keiji Horike et al.
NEPHROLOGY (2018)
Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation
Isabel Morgado et al.
BIOCHEMISTRY (2018)
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Merrill D. Benson et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)
Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII
Samih H. Nasr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Apolipoprotein A-IV-Associated Cardiac Amyloidosis
Melanie C. Bois et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Apolipoprotein A-1-related amyloidosis 2 case reports and review of the literature
Chunlei Lu et al.
MEDICINE (2017)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu et al.
NEURON (2017)
Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder
Charlotte Koopal et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant
Tatiana Prokaeva et al.
KIDNEY INTERNATIONAL REPORTS (2017)
A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype
Birgitte G. Tougaard et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2016)
Apolipoprotein A-I: the dual face of a protein
Angela Arciello et al.
FEBS LETTERS (2016)
Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis
Surendra Dasari et al.
KIDNEY INTERNATIONAL (2016)
Diagnosis and treatment of high density lipoprotein deficiency
Ernst J. Schaefer et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
Sophie Valleix et al.
NATURE COMMUNICATIONS (2016)
Amyloid cardiomyopathy associated with a novel apolipoprotein A-I Q172P variant
Frederick W. Vonberg et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis
Gina Gregorini et al.
KIDNEY INTERNATIONAL (2015)
The amyloid state and its association with protein misfolding diseases
Tuomas P. J. Knowles et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I
Dorota Rowczenio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Renal amyloidosis caused by apolipoprotein A-II without a genetic mutation in the coding sequence
Ryuji Morizane et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Hereditary Apolipoprotein Al-Associated Amyloidosis in Surgical Pathology Specimens Identification of Three Novel Mutations in the APOA1 Gene
Magdalena Eriksson et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
The workings of the amyloid diseases
Vittorio Bellotti et al.
ANNALS OF MEDICINE (2007)
Apolipoprotein E4 is associated with primary localized cutaneous amyloidosis
H Furumoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred
D Takada et al.
JOURNAL OF HUMAN GENETICS (2002)
Share Paper
